The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant

(2014) S. Adams et al.   JOURNAL OF IMMUNOLOGY

Involvement of toll-like receptor 9 polymorphism in cervical cancer development

(2012) Andrzej Roszak et al.   MOLECULAR BIOLOGY REPORTS

Some highlights of the first century of immunotherapy

(2011) Harold S. Nelson   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis

(2011) Evy Gillet et al.   BMC INFECTIOUS DISEASES

Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment

(2011) Correne A. DeCarlo et al.   Clinical & Developmental Immunology

Immune functions of the skin

(2011) Christine Bangert et al.   CLINICS IN DERMATOLOGY

Cervical cancer in the human papillomavirus vaccination era

(2011) Sun-Kuie Tay   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9

(2011) Ana M. Avalos et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase

(2011) Sarah E. Ewald et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands

(2011) Shin Morizane et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene Expression

(2011) J. Reiser et al.   JOURNAL OF VIROLOGY

I B Kinase   Promotes Cell Survival by Antagonizing p53 Functions through  Np73  Phosphorylation and Stabilization

(2011) R. Accardi et al.   MOLECULAR AND CELLULAR BIOLOGY

Estrogen dependent signaling in reproductive tissues – A role for estrogen receptors and estrogen related receptors

(2011) Douglas A. Gibson et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes

(2011) Rezaul Karim et al.   PLoS One

Hepatitis B Virus Lacks Immune Activating Capacity, but Actively Inhibits Plasmacytoid Dendritic Cell Function

(2011) Andrea M. Woltman et al.   PLoS One

The Histone Demethylase Jarid1b (Kdm5b) Is a Novel Component of the Rb Pathway and Associates with E2f-Target Genes in MEFs during Senescence

(2011) Jeroen H. Nijwening et al.   PLoS One

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells

(2011) Isabelle E. Vincent et al.   PLoS One

Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10

(2010) Joanna Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003

(2010) A. Blythe Ryerson et al.   CANCER

Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia

(2010) Li Yu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Association between toll-like receptor expression and human papillomavirus type 16 persistence

(2010) Ibrahim I. Daud et al.   INTERNATIONAL JOURNAL OF CANCER

TLR9 Contributes to the Recognition of EBV by Primary Monocytes and Plasmacytoid Dendritic Cells

(2010) S. Fiola et al.   JOURNAL OF IMMUNOLOGY

EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9

(2010) I. Fathallah et al.   JOURNAL OF IMMUNOLOGY

EBV Lytic-Phase Protein BGLF5 Contributes to TLR9 Downregulation during Productive Infection

(2010) M. van Gent et al.   JOURNAL OF IMMUNOLOGY

Human Papillomavirus Type 16 E6/E7 Upregulation of Nucleophosmin Is Important for Proliferation and Inhibition of Differentiation

(2010) R. McCloskey et al.   JOURNAL OF VIROLOGY

HPV-associated head and neck cancer: a virus-related cancer epidemic

(2010) Shanthi Marur et al.   LANCET ONCOLOGY

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses

(2010) Vijay A K Rathinam et al.   NATURE IMMUNOLOGY

TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification

(2010) L Zauner et al.   ONCOGENE

Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3

(2010) M. Sasai et al.   SCIENCE

Histone demethylases in development and disease

(2010) Marianne Terndrup Pedersen et al.   TRENDS IN CELL BIOLOGY

Estrogen and ERα: Culprits in cervical cancer?

(2010) Sang-Hyuk Chung et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer

(2010) Ivan Hirsch et al.   TRENDS IN IMMUNOLOGY

Epigenetic Silencing of Interferon-  in Human Papillomavirus Type 16-Positive Cells

(2009) B. Rincon-Orozco et al.   CANCER RESEARCH

Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment

(2009) Z. Lin et al.   CLINICAL CANCER RESEARCH

Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells

(2009) Fernando E. Sepulveda et al.   IMMUNITY

E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells

(2009) T. Rampias et al.   JNCI-Journal of the National Cancer Institute

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells

(2009) Yongfen Xu et al.   MOLECULAR IMMUNOLOGY

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

(2009) Teresa Fernandes-Alnemri et al.   NATURE

Hepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1

(2009) Françoise Gondois-Rey et al.   PLoS One

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists

(2009) S.-H. Chung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers

(2008) A. Shai et al.   CANCER RESEARCH

Requirement for Estrogen Receptor   in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer

(2008) S.-H. Chung et al.   CANCER RESEARCH

Validation of Reference Genes in Cervical Cell Samples from Human Papillomavirus-Infected and -Uninfected Women for Quantitative Reverse Transcription-PCR Assays

(2008) I. I. Daud et al.   Clinical and Vaccine Immunology

Mast cell functions in the innate skin immune system

(2008) Martin Metz et al.   IMMUNOBIOLOGY

The Histone Demethylase KDM5b/JARID1b Plays a Role in Cell Fate Decisions by Blocking Terminal Differentiation

(2008) B. K. Dey et al.   MOLECULAR AND CELLULAR BIOLOGY